[1] |
Dalbeth, N.; Gosling, A.L.; Gaffo, A.; Abhishek, A. Gout. Lancet. 2021, 10287, 1843–1855.
|
[2] |
Hansildaar, R.; Vedder, D.; Baniaamam, M.; Tausche, A.K.; Gerritsen, M.; Nurmohamed, M.T. Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol. 2021, 3, e58–e70.
|
[3] |
Safiri, S.; Kolahi, A.A.; Cross, M.; Hill, C.; Smith, E.; Carson-Chahhoud, K.; Mansournia, M.A.; Almasi-Hashiani, A.; Ashrafi-Asgarabad, A.; Kaufman, J.; Sepidarkish, M.; Shakouri, S.K.; Hoy, D.; Woolf, A.D.; March, L.; Collins, G.; Buchbinder, R. Prevalence, deaths, and disability-adjusted life years due to musculoskeletal disorders for 195 countries and territories 1990-2017. Arthritis Rheumatol. 2021, 73, 702–714.
|
[4] |
Li, L.J.; Zhang, Y.P.; Zeng, C.C. Update on the epidemiology, genetics, and therapeutic options of hyperuricemia. Am. J. Transl. Res. 2020, 12, 3167–3181.
|
[5] |
Chowalloor, P.V.; Keen, H.I. A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia. Ann. Rheum. Dis. 2013, 72, 638–645.
|
[6] |
Zhang, Y.Y.; Zhang, P.P.; Ding, H.X.; Zhang, X.; Liu, Y. HH-A, a honokiol derivative, alleviates hypoxic brain injury in the animal ischemic model by interacting with hemoglobin. J. Chin. Pharm. Sci. 2024, 33, 98.
|
[7] |
McGrath, J.C.; Drummond, G.B.; McLachlan, E.M.; Kilkenny, C.; Wainwright, C.L. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br. J. Pharmacol. 2010, 160, 1573–1576.
|
[8] |
Li, F.C.; Zhang, D.; Li, Z.; Hou, Z.M.; Chen, W.; Chen, J.; Hu, Y.Q. Exploring the landscape of stem cell research for Alzheimer’s disease: a bibliometric analysis spanning 2002–2021. J. Chin. Pharm. Sci. 2023, 32, 813.
|
[9] |
Yu, K.; Hao, L.; Bu, F.; Guo, Y.; Duan, Y.; Hu, R. Knowledge structure and emerging trends of cognitive impairment induced by sleep deprivation: a bibliometric analysis based on CiteSpace and VOSviewer from 2000 to 2022: Erratum. Medicine. 2024, 103, e37557.
|
[10] |
Ellegaard, O.; Wallin, J.A. The bibliometric analysis of scholarly production: How great is the impact? Scientometrics. 2015, 105, 1809–1831.
|
[11] |
Lu, J.; Hou, X.; Yuan, X.; Cui, L.L.; Liu, Z.; Li, X.D.; Ma, L.D.; Cheng, X.Y.; Xin, Y.; Wang, C.; Zhang, K.K.; Wang, X.F.; Ren, W.; Sun, R.X.; Jia, Z.T.; Tian, Z.B.; Mi, Q.S.; Li, C.G. Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders. Kidney Int. 2018, 93, 69–80.
|
[12] |
Lu, J.; He, Y.W.; Cui, L.L.; Xing, X.M.; Liu, Z.; Li, X.D.; Zhang, H.; Li, H.L.; Sun, W.Y.; Ji, A.C.; Wang, Y.; Yin, H.Y.; Li, C.G. Hyperuricemia predisposes to the onset of diabetes via promoting pancreatic β-cell death in uricase-deficient male mice. Diabetes. 2020, 69, 1149–1163.
|
[13] |
Li, D.L.; Yuan, S.Y.; Deng, Y.Y.; Wang, X.W.; Wu, S.H.; Chen, X.S.; Li, Y.M.; Ouyang, J.T.; Lin, D.Y.; Quan, H.H.; Fu, X.W.; Li, C.; Mao, W. The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. Front. Immunol. 2023, 14, 1282890.
|
[14] |
Liang, J.H.; Yi, X.L.; Gong, J.M.; Du, Z. Evaluation of the inhibitory effects of antigout drugs on human carboxylesterases in vitro. Toxicol. Vitro. 2024, 98, 105833.
|
[15] |
Yokose, C.; Challener, G.; Jiang, B.H.; Zhou, B.J.; McCormick, N.; Tanikella, S.; Panchot, K.M.Q.; Kohler, M.J.; Yinh, J.; Zhang, Y.Q.; Bates, D.W.; Januzzi, J.L.; Sise, M.; Wexler, D.; Choi, H.K. Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: a comparative effectiveness analysis. Semin. Arthritis Rheum. 2024, 66, 152441.
|